请输入您要查询的百科知识:

 

词条 Insert Therapeutics
释义

  1. References

  2. External links

Insert Therapeutics, Inc., now Calando Pharmaceuticals, Inc., is a medical research company that uses nanobiotechnology specializing in therapeutic agents that are conjugated, to facilitate and enhance drug delivery. The small company was founded in 2000, is located in Pasadena, California, and is owned by Arrowhead Research Corporation.[1]

The conjugates consist of a cyclodextrin-containing polymer (Cyclosert) that acts as a drug delivery system, and a linked medication, such as a chemotherapeutic drug of already proven efficacy.[2] The size of the polymer is designed to “fit” the specific target, as vessels in a neoplasm allow for leakage of different sizes of polymers, as in healthy tissue. The leaked conjugates are concentrated in the target area. As a result, chemotherapeutic activity is locally enhanced, while general side effects are decreased.[2]

At least one of their conjugates, IT-101, has been investigated in a clinical trial at City of Hope National Medical Center.[2]

References

1. ^{{cite web|url=http://ctventures.com/portfolio/insert-therapeutics/|title=Insert Therapeutics, Inc.|publisher=ctventures.com|access-date=1 February 2018}}
2. ^IT-101 trial

External links

  • Calando Pharmaceuticals, Inc. was Insert Therapeutics, Inc.
  • Cerulean Pharma, Inc. IT-101 licensee

1 : Biotechnology companies

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/12 5:20:17